Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-18

Clinical Trial Update: Dexmedetomidine Reduce Postoperative Pain of C-section [Phase 4]

View source ↗

Summary

Phase 4 trial investigating dexmedetomidine for reducing postoperative pain after cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: First People's Hospital of Chenzhou | Conditions: Pain, Postoperative | Phase 4 | Status: UNKNOWN